• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login
Search
Generic filters
Home » All News » Nimbus Synergies Leads $20 Million Strategic Investment in Clarius Mobile Health to Accelerate Growth

All News

  • Member News
  • Industry News
  • LSBC in The News
Member News

Nimbus Synergies Leads $20 Million Strategic Investment in Clarius Mobile Health to Accelerate Growth

March 15, 2022 – Nimbus Synergies

Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce the completion of a $20 million strategic investment in Clarius Mobile Health. This new investment was led by Nimbus Synergies and Export Development Canada to enable Clarius to expand its commercial scale and capitalize on the momentum created by the introduction of the company’s third-generation product line earlier this year. New investor, Nicola Wealth, as well as existing investors, BMO Capital Partners and Pender Ventures, also participated in the round.

Clarius Mobile Health is a leading provider of high-definition wireless ultrasound systems. Clarius wireless scanners are used in hospitals, private practices, and veterinary clinics around the world. Designed for all medical specialists, the new third-generation pocket-sized scanners are 30% lighter and smaller and available in the United States with compelling pricing and new features.

Point-of-care ultrasound (“POCUS”) is the new stethoscope and Clarius’ exceptional performance in 2021, which delivered 100% revenue growth year-over-year, and increasing focus on artificial intelligence and Software-as-a-Service (SaaS) to deliver an uncompromising handheld ultrasound solution, underscores the market opportunity for a leader in this industry. Furthermore, the company’s recently launched SaaS model is gaining strong adoption with users highlighting the company’s ability to leverage its hardware and software expertise for an integrated, intuitive, and exceptional customer experience.

“Today, Clarius is the most disruptive ultrasound platform company in the market”, said Paul Geyer, CEO of Nimbus Synergies. “Fusing high performance ultrasound imaging, cloud data and artificial intelligence in a powerful ecosystem that provides significant clinical value to improve patient care. The company has been extremely capital efficient to date, and we know these additional funds will fuel even faster growth.”

Geyer, who will be joining the company’s Board, is a successful medtech entrepreneur, investor, experienced Board member, and venture capitalist. Over the past 25 years, he has founded or led three companies through their growth phases, two of which have become anchor medical device companies in the Vancouver, BC area, employing more than 350 people.

“We are very pleased to welcome Nimbus Synergies to our syndicate and to continue working with such a committed group of investors,” commented Maria Pacella, Managing Partner of Pender Ventures. “We are also enthused to leverage Paul’s knowledge and expertise as part of our Board moving forward.”

“Paul is a recognized leader both in the medical technology sector as a successful serial entrepreneur as well as in the broader innovation and early-stage investment ecosystem as an investor,” explained Clarius’ President, Ohad Arazi. “Paul has served on numerous Boards, is one of the most active and respected medtech investors in British Columbia, and, with Nimbus Synergies, is a welcomed partner in venture capital,” continued Arazi.

ABOUT NIMBUS SYNERGIES

Nimbus Synergies leads early-stage financings in innovative and complementary health technology companies in Canada. By bringing these companies together to share resources, industry specific knowledge, and relationships, Nimbus is accelerating their growth and increasing their likelihood of success. Nimbus is significantly impacting the health technology sector through its leadership as investor, partner, and mentor.

Follow Nimbus Synergies on LinkedIn (https://www.linkedin.com/company/nimbus-synergies) and Twitter @nimbussynergies

ABOUT CLARIUS MOBILE HEALTH

Clarius is on a mission to make accurate, easy-to-use, and affordable ultrasound tools available to all medical professionals in every specialty. With decades of experience in medical imaging, the team knows that great ultrasound imaging improves confidence and patient care. Today, Clarius handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost.

Nearly two million high-definition scans have been performed using Clarius wireless handheld scanners. Clarius scanners are available in over 90 countries worldwide.

Learn more at www.clarius.com.

Original source here.

Primary Sidebar

  • Category:

  • Sector:

  • Archives:

© 2022 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us